Yubo International Biotech Ltd
YBGJ· OTC
YBGJYubo International Biotech Ltd
Filed Apr 14, 2023 · 10-K · 104 days after period end · 0001640334-23-000632
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $66.52K | — | — | — |
| Net Income | $103.61K | -$397.17K | -$438.68K | -$140.95K |
| EPS Diluted | — | — | $0.00 | $0.00 |
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Apr 14, 2023 · 104 d after period end
